Sequential CX Ripening: Which Should Be First? episode artwork

EPISODE · Jul 21, 2024 · 45 MIN

Sequential CX Ripening: Which Should Be First?

from Dr. Chapa’s OBGYN Clinical Pearls · host Dr. Chapa’s Clinical Pearls

Published studies, including 2 large network meta-analyses, support the safety and efficacy of misoprostol (PG E1) when used for cervical ripening and labor induction. Based on cumulative data, misoprostol administered vaginally at doses of 50 μg has the highest probability of achieving vaginal delivery within 24 hours. Prostaglandin E2 also has proven efficacy. Plus, we are all aware of the safety and efficacy of mechanical methods of cervical ripening; yes…we know that these options may be used either individually or concomitantly. But what about sequential use? Can cervical balloon be used after misoprostol? Or should it be the other way around? Is there a “best way” to do sequential cervical ripening? This episode topic comes from one of our podcast family members. It's a really good clinical question, and we will dive into the data in this episode. And STAY TUNED IN UNTIL THE END for the real-world clinical implications of the data.

Episode metadata supplied by the publisher feed · Published Jul 21, 2024

Embed this episode

NOW PLAYING

Sequential CX Ripening: Which Should Be First?

0:00 45:52

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Dr. Chapa’s OBGYN Clinical Pearls?

This episode is 45 minutes long.

When was this Dr. Chapa’s OBGYN Clinical Pearls episode published?

This episode was published on July 21, 2024.

Can I download this Dr. Chapa’s OBGYN Clinical Pearls episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!